Following the completion of the Phase II clinical development of IMVAMUNE®, a third-generation smallpox vaccine, Bavarian Nordic has held an end of Phase II meeting with the FDA to discuss the Phase III development. The meeting was a success and there was an open and highly constructive discussion with the FDA. biotech information
France Biotech has published the 3rd edition of its annual Drug Pipeline Review. The survey was part-funded by the French Ministry of the Economy, Industry & Finance. The study summarizes and analyses data collected in 2008 on 227 healthcare products under development, including 158 drugs (at 51 life science companies), 41 in vitro diagnostics (at 22 companies) and 28 medical devices (at 17 companies). biotech information
Ascenta Therapeutics announced positive preliminary results from its Phase II study of AT-101 in combination with docetaxel and prednisone (D/P) in men with docetaxel refractory, castrate resistant prostate cancer (CRPC) at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in Orlando, FL. biotech information
HITRUST Alliance and Healthcare Leaders Collaborate to Change the Way Health Information is Protected (Centre Daily Times)With the dramatic rise in breaches, theft of patient health data and the increase in regulatory requirements such as those mandated by the American Recovery and Reinvestment Act of 2009 – healthcare organizations and their business partners are now under intense pressure and scrutiny regarding security and privacy. But without a fundamental change in approach the industry will continue to see .
FS-BT: [Food Security and Ag-Biotech News]Food Security and Ag-Biotech News is an example of the tools and strategies developed by Meridian to support collaborative problem solving processes. Please visit http://www.merid.org/fs-agbiotech/ For more information about Food .
New regulations are on the way for organic food in Canada, where cloned animals will be excluded; and for genetic information in the U.S., where the EEOC started hearings to implement Title II of the Genetic Information .This Week’s Biotech Highlights >> Slaw
